AKT1 and prostate carcinoma: Previous studies suggest that cordycepin inhibits MMP-2 and MMP-9 expression and suppresses MAPK/AP-1 and Akt/PI3K pathways in breast cancer and prostate carcinoma cells, suppressing cancer invasiveness [7, 38].